Colonial Trust Advisors’s Calliditas Therapeutics AB American Depositary Shares CALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-105
Closed -$4.09K 780
2024
Q2
$4.09K Hold
105
﹤0.01% 631
2024
Q1
$2.21K Hold
105
﹤0.01% 792
2023
Q4
$2.7K Hold
105
﹤0.01% 676
2023
Q3
$1.92K Hold
105
﹤0.01% 726
2023
Q2
$1.66K Hold
105
﹤0.01% 758
2023
Q1
$2.52K Hold
105
﹤0.01% 702
2022
Q4
$1.78K Buy
+105
New +$1.69K ﹤0.01% 738

Other funds holding CALT

Colonial Trust Advisors's CALT Position: Q3 2024 in Review

Colonial Trust Advisors sold out of Calliditas Therapeutics AB American Depositary Shares (CALT) in Q3 2024, closing a stake of 105 shares — an estimated $4.09K sold.

Colonial Trust Advisors first reported a position in CALT in Q4 2022 and held it in 7 quarters. The position peaked at $4.09K in Q2 2024. 5 funds tracked by Wall St. Rank hold CALT as of Q3 2024.

  • Colonial Trust Advisors reported no remaining Calliditas Therapeutics AB American Depositary Shares position as of Q3 2024 after selling out during the quarter.
  • Colonial Trust Advisors sold 105 Calliditas Therapeutics AB American Depositary Shares shares in Q3 2024, an estimated $4.09K.
  • Colonial Trust Advisors first reported a position in Calliditas Therapeutics AB American Depositary Shares in Q4 2022 and held it in 7 quarters.
  • Colonial Trust Advisors's Calliditas Therapeutics AB American Depositary Shares position peaked at $4.09K in Q2 2024.
  • 5 funds tracked by Wall St. Rank held Calliditas Therapeutics AB American Depositary Shares as of Q3 2024.

Based on Colonial Trust Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.